155 related articles for article (PubMed ID: 2495349)
1. Interferon-gamma concentrations are increased in sera from individuals infected with human immunodeficiency virus type 1.
Fuchs D; Hausen A; Reibnegger G; Werner ER; Werner-Felmayer G; Dierich MP; Wachter H
J Acquir Immune Defic Syndr (1988); 1989; 2(2):158-62. PubMed ID: 2495349
[TBL] [Abstract][Full Text] [Related]
2. Increased endogenous interferon-gamma and neopterin correlate with increased degradation of tryptophan in human immunodeficiency virus type 1 infection.
Fuchs D; Möller AA; Reibnegger G; Werner ER; Werner-Felmayer G; Dierich MP; Wachter H
Immunol Lett; 1991 Jun; 28(3):207-11. PubMed ID: 1909303
[TBL] [Abstract][Full Text] [Related]
3. Neopterin and interferon-gamma in serum and cerebrospinal fluid of patients with HIV-associated neurologic disease.
Griffin DE; McArthur JC; Cornblath DR
Neurology; 1991 Jan; 41(1):69-74. PubMed ID: 1898675
[TBL] [Abstract][Full Text] [Related]
4. Correlation of in vitro immune defects with impaired gamma interferon response in human-immunodeficiency-virus-infected individuals.
Rudy T; Opelz G; Gerlach R; Daniel V; Schimpf K
Vox Sang; 1988; 54(2):92-5. PubMed ID: 3131964
[TBL] [Abstract][Full Text] [Related]
5. Decreased serum tryptophan in patients with HIV-1 infection correlates with increased serum neopterin and with neurologic/psychiatric symptoms.
Fuchs D; Möller AA; Reibnegger G; Stöckle E; Werner ER; Wachter H
J Acquir Immune Defic Syndr (1988); 1990; 3(9):873-6. PubMed ID: 2166783
[TBL] [Abstract][Full Text] [Related]
6. Increased serum neopterin in patients with HIV-1 infection is correlated with reduced in vitro interleukin-2 production.
Fuchs D; Shearer GM; Boswell RN; Clerici M; Reibnegger G; Werner ER; Zajac RA; Wachter H
Clin Exp Immunol; 1990 Apr; 80(1):44-8. PubMed ID: 1969780
[TBL] [Abstract][Full Text] [Related]
7. Immune activation and decreased tryptophan in patients with HIV-1 infection.
Fuchs D; Forsman A; Hagberg L; Larsson M; Norkrans G; Reibnegger G; Werner ER; Wachter H
J Interferon Res; 1990 Dec; 10(6):599-603. PubMed ID: 2128302
[TBL] [Abstract][Full Text] [Related]
8. Neopterin concentrations in cerebrospinal fluid and serum of individuals infected with HIV-1.
Fuchs D; Chiodi F; Albert J; Asjö B; Hagberg L; Hausen A; Norkrans G; Reibnegger G; Werner ER; Wachter H
AIDS; 1989 May; 3(5):285-8. PubMed ID: 2504232
[TBL] [Abstract][Full Text] [Related]
9. Neopterin and alpha and beta interleukin-1 levels in sera of patients with human immunodeficiency virus infection.
Reddy MM; Grieco MH
J Clin Microbiol; 1989 Sep; 27(9):1919-23. PubMed ID: 2789233
[TBL] [Abstract][Full Text] [Related]
10. Neopterin estimation compared with the ratio of T-cell subpopulations in persons infected with human immunodeficiency virus-1.
Fuchs D; Banekovich M; Hausen A; Hutterer J; Reibnegger G; Werner ER; Gschnait FD; Dierich MP; Wachter H
Clin Chem; 1988 Dec; 34(12):2415-7. PubMed ID: 3264225
[TBL] [Abstract][Full Text] [Related]
11. Cytokine network and acute primary HIV-1 infection.
Sinicco A; Biglino A; Sciandra M; Forno B; Pollono AM; Raiteri R; Gioannini P
AIDS; 1993 Sep; 7(9):1167-72. PubMed ID: 8216972
[TBL] [Abstract][Full Text] [Related]
12. Stimulated cellular immune system in patients with congestive heart failure.
Fuchs D; Samsonov M; Tilz GP; Reibnegger G; Belenkov JN; Nassonov EL; Wachter H
Eur J Clin Chem Clin Biochem; 1993 Mar; 31(3):111-4. PubMed ID: 8490055
[TBL] [Abstract][Full Text] [Related]
13. Neopterin and interferon gamma serum levels in patients with heart and kidney transplants.
Woloszczuk W; Schwarz M; Havel M; Laczkovics A; Müller MM
J Clin Chem Clin Biochem; 1986 Oct; 24(10):729-34. PubMed ID: 3097241
[TBL] [Abstract][Full Text] [Related]
14. Tryptophan degradation in patients infected by human immunodeficiency virus.
Werner ER; Fuchs D; Hausen A; Jaeger H; Reibnegger G; Werner-Felmayer G; Dierich MP; Wachter H
Biol Chem Hoppe Seyler; 1988 May; 369(5):337-40. PubMed ID: 3166737
[TBL] [Abstract][Full Text] [Related]
15. Correlation between neopterin, interferon-gamma and haemoglobin in patients with haematological disorders.
Denz H; Fuchs D; Huber H; Nachbaur D; Reibnegger G; Thaler J; Werner ER; Wachter H
Eur J Haematol; 1990 Mar; 44(3):186-9. PubMed ID: 2109703
[TBL] [Abstract][Full Text] [Related]
16. Raised levels of tumour necrosis factor-alpha and neopterin, but not interferon-alpha, in serum of HIV-1-infected patients from Ethiopia.
Ayehunie S; Sonnerborg A; Yemane-Berhan T; Zewdie DW; Britton S; Strannegard O
Clin Exp Immunol; 1993 Jan; 91(1):37-42. PubMed ID: 8419084
[TBL] [Abstract][Full Text] [Related]
17. Immune activation markers to predict AIDS and survival in HIV-1 seropositives.
Fuchs D; Jäger H; Popescu M; Reibnegger G; Werner ER; Dierich MP; Kaboth W; Tilz GP; Wachter H
Immunol Lett; 1990 Oct; 26(1):75-9. PubMed ID: 2125976
[TBL] [Abstract][Full Text] [Related]
18. Increased serum concentrations of soluble tumor necrosis factor receptors in HIV-infected individuals are associated with immune activation.
Zangerle R; Gallati H; Sarcletti M; Weiss G; Denz H; Wachter H; Fuchs D
J Acquir Immune Defic Syndr (1988); 1994 Jan; 7(1):79-85. PubMed ID: 7903382
[TBL] [Abstract][Full Text] [Related]
19. Serum 27E10 antigen: a new potential marker for staging HIV disease.
Lügering N; Stoll R; Kucharzik T; Burmeister G; Sorg C; Domschke W
Clin Exp Immunol; 1995 Aug; 101(2):249-53. PubMed ID: 7648708
[TBL] [Abstract][Full Text] [Related]
20. Serum neopterin changes in HIV-infected subjects: indicator of significant pathology, CD4 T cell changes, and the development of AIDS.
Melmed RN; Taylor JM; Detels R; Bozorgmehri M; Fahey JL
J Acquir Immune Defic Syndr (1988); 1989; 2(1):70-6. PubMed ID: 2783972
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
